Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis
Open Access
- 28 November 2019
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 9 (2) , 745-756
Abstract
Background: Gene mutations may play an important role in the development, response to treatment and prognosis of colorectal cancer (CRC). This retrospective study aimed to investigate the mutation profiling of Chinese patients with CRC, and its correlation with clinicopathological features and prognosis.Methods: This study included 1190 Chinese CRC patients who were diagnosed between May 1998 and December 2018 and received clinical genetic testing. The OncoCarta Panel was used to test a total of 238 possible mutations in 19 common oncogenes.Results: Five hundred and eighty‐two (48.9%) cases were detected with gene mutations. Of the 582 cases, there were 111 cases (19.7%) with two concurrent mutations, and six cases (1.0%) with three concurrent mutations. KRAS was the most common gene mutation that occurred in all cases (429, 36.1%), followed by PIK3CA (121, 10.2%), NRAS (47, 3.9%), BRAF (35, 2.9%), HRAS (11, 0.9%) and epidermal growth factor receptor (EGFR) (11, 0.9%). AKT1, KIT, FGFR1, FGFR3, FLT3, CDK, ERBB2, ABL1, MET, RET and PDGFRA mutations were also detected in several cases. When it came to prognosis, we found that KRAS/NRAS/PIK3CA/BRAF mutation was not associated with prognosis. But BRAF mutation was associated with poor prognosis in patients who accepted anti‐EGFR therapy.Conclusions: The molecular testing offered the clinical data and mutation profile of Chinese CRC patients. The information of these mutated genes may help to find out the correlation between mutated genes and the development or prognosis of CRC.Keywords
Funding Information
- National Natural Science Foundation of China (81602066, 81602426)
- Natural Science Foundation of Guangdong Province (2016A030310198)
- Fundamental Research Funds for the Central Universities (16ykpy25)
This publication has 43 references indexed in Scilit:
- Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patientsMedical Oncology, 2013
- Prognostic and Predictive Roles of KRAS Mutation in Colorectal CancerInternational Journal of Molecular Sciences, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon CancerJournal of Clinical Oncology, 2009
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal AntibodiesCancer Research, 2009
- Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanismsProceedings of the National Academy of Sciences, 2008
- Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceAdvances in Enzyme Regulation, 2006
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004
- Comparison of fermentation reactions in different regions of the human colonJournal of Applied Bacteriology, 1992